Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A Novel Treatment for Proliferative Diabetic Retinopathy: Anti-Vascular Endothelial Growth Factor Therapy.

× No keyword cloud information.

11 in total

1. Rationale and Application of the Protocol S Anti-Vascular Endothelial Growth Factor Algorithm for Proliferative Diabetic Retinopathy.

Authors: Jennifer K Sun; Adam R Glassman; Wesley T Beaulieu; Cynthia R Stockdale; Neil M Bressler; Christina Flaxel; Jeffrey G Gross; Michel Shami; Lee M Jampol
Journal: Ophthalmology Date: 2018-08-07 Impact factor: 12.079

Review 2. Presence and Risk Factors for Glaucoma in Patients with Diabetes.

Authors: Brian J Song; Lloyd Paul Aiello; Louis R Pasquale
Journal: Curr Diab Rep Date: 2016-12 Impact factor: 4.810

3. Sensitivity and specificity of pseudocolor ultrawide field imaging in comparison to wide field fundus fluorescein angiography in detecting retinal neovascularization in diabetic retinopathy.

Authors: Swathy Haridas; Swati Indurkhya; Sailesh Kumar; Anantharaman Giridhar; Sobha Sivaprasad
Journal: Eye (Lond) Date: 2021-09-28 Impact factor: 4.456

4. Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.

Authors: Jeffrey G Gross; Adam R Glassman; Danni Liu; Jennifer K Sun; Andrew N Antoszyk; Carl W Baker; Neil M Bressler; Michael J Elman; Frederick L Ferris; Thomas W Gardner; Lee M Jampol; Daniel F Martin; Michele Melia; Cynthia R Stockdale; Roy W Beck
Journal: JAMA Ophthalmol Date: 2018-10-01 Impact factor: 7.389

5. Anti-Vascular Endothelial Growth Factor Therapy as an Alternative or Adjunct to Pan-Retinal Photocoagulation in Treating Proliferative Diabetic Retinopathy: Meta-Analysis of Randomized Trials.

Authors: Shuang Gao; Zhongjing Lin; Xi Shen
Journal: Front Pharmacol Date: 2020-06-05 Impact factor: 5.810

6. CHANGES IN PLASMA VASCULAR ENDOTHELIAL GROWTH FACTOR LEVEL AFTER INTRAVITREAL INJECTION OF BEVACIZUMAB, AFLIBERCEPT, OR RANIBIZUMAB FOR DIABETIC MACULAR EDEMA.

Authors: Takao Hirano; Yuichi Toriyama; Yasuhiro Iesato; Akira Imai; Toshinori Murata
Journal: Retina Date: 2018-09 Impact factor: 4.256

Review 7. Remodeling of Retinal Architecture in Diabetic Retinopathy: Disruption of Ocular Physiology and Visual Functions by Inflammatory Gene Products and Pyroptosis.

Authors: Rubens P Homme; Mahavir Singh; Avisek Majumder; Akash K George; Kavya Nair; Harpal S Sandhu; Neetu Tyagi; David Lominadze; Suresh C Tyagi
Journal: Front Physiol Date: 2018-09-05 Impact factor: 4.566

8. Hu-Zhang-Qing-Mai-Yin Inhibits Proliferation of Human Retinal Capillary Endothelial Cells Exposed to High Glucose.

Authors: Yuan-Yuan Yu; Qiu-Ping Liu; Meng-Ting Li; Pei An; Yu-Ying Chen; Xin Luan; Chao Lv; Hong Zhang
Journal: Front Pharmacol Date: 2021-08-06 Impact factor: 5.810

9. Single-dose Intravitreal Bevacizumab after Complete Panretinal Photocoagulation in Proliferative Diabetic Retinopathy: an Effective Adjunctive Treatment.

Authors: Alireza Dehghani; Heshmatollah Ghanbari; Abdolsamad Mahdizadeh; Mohsen Pourazizi
Journal: Med Hypothesis Discov Innov Ophthalmol Date: 2017

10. Efficacy and Safety of Intravitreal Conbercept, Ranibizumab, and Triamcinolone on 23-Gauge Vitrectomy for Patients with Proliferative Diabetic Retinopathy.

Authors: Jinglin Cui; Hong Chen; Hang Lu; Fangtian Dong; Dongmei Wei; Yan Jiao; Steve Charles; Weikuan Gu; Lin Wang
Journal: J Ophthalmol Date: 2018-06-25 Impact factor: 1.909